Table 2:

EQ-5D-5L utility scores in CNS tumor patients at pre-operative and progressive disease periods, when categorized by histology and disease severity.

Characteristics	EQ-5D-5L utility scores, Mean (95% CI)
	n	Pre-operative	n	Progressive disease
All intracranial tumor	123	0.711 (0.662–0.760)	18	0.261 (0.144–0.378)
Intracranial tumor divided by histology
Glioma	37	0.584 (0.487–0.681)	18	0.261 (0.144–0.378)
Glioblastoma	22	0.554 (0.414–0.694)	11	0.289* (0.131–0.446)
Other Glioma	15	0.628* (0.488–0.768)	7	0.217 (−0.013–0.446)
Meningioma	45	0.753 (0.676–0.830)	0	NA
Schwannoma	8	0.771 (0.490–1.000)	0	NA
Pituitary adenoma	15	0.859 (0.784–0.935)	0	NA
Brain metastasis	10	0.821* (0.698–0.943)	0	NA
Other brain tumor	8	0.584* (0.327–0.842)	0	NA
Intracranial tumor divided by disease severity
Benign	83	0.742 (0.684–0.799)	4	0.197* (−0.147–0.541)
Malignant	40	0.647 (0.553–0.740)	14	0.279 (0.137–0.420)
P-value†	0.072			0.557

^*Normal distribution by Shapiro–Wilk test, ^†t-test with bias-corrected and accelerated non-parametric bootstrap technique compared between different malignancy status, n=Number of total patients, NA=Not available